top of page
.png)
Search
ARQon
Dec 102 min read
China: NMPA Introduces Interim Provisions on Domestic Responsible Persons Designated by Overseas Drug Marketing Authorization Holders (w.e.f 1 July 2025)
To enforce the Drug Administration Law of the People’s Republic of China and the Vaccine Administration Law of the People’s Republic of...
3 views0 comments
ARQon
Jul 161 min read
China: NMPA Outlines New Standards for Radiofrequency Therapy Devices (w.e.f 1 April 2026)
On the 2nd of July 2024, the Centre for Medical Device Evaluation (CMDE) announced the clarification by the National Medical Products...
10 views0 comments
ARQon
May 281 min read
China: Optimization of Registration Application for Transferring Overseas-Produced Drugs into Domestic Production
As part of the initiative to boost foreign investments in the pharmaceutical industry and improve high-quality drug developments and...
11 views0 comments
bottom of page